Skin preparation for prevention of surgical site infection after cesarean delivery

Obstetrics and Gynecology

Volumn 126, Issue 6, 2015, Pages 1251-1257

  Ngai, Ivan M ^a   Van Arsdale, Anne ^a   Govindappagari, Shravya ^a   Judge, Nancy E ^a   Neto, Nicole K ^a   Bernstein, Jeffrey ^a   Bernstein, Peter S ^a   Garry, David J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIBIOTIC AGENT; CHLORHEXIDINE; POVIDONE IODINE; 2 PROPANOL; DRUG COMBINATION; TOPICAL ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ANTISEPSIS; ARTICLE; CESAREAN SECTION; CHORIOAMNIONITIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFICACY; EVIDENCE BASED PRACTICE; FEMALE; GESTATIONAL AGE; HUMAN; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURGICAL INFECTION; SURGICAL PATIENT; TREATMENT INDICATION; COMPARATIVE STUDY; DRUG COMBINATION; INTRADERMAL DRUG ADMINISTRATION; PREGNANCY; PREOPERATIVE CARE; PROCEDURES; STATISTICAL MODEL; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

2-PROPANOL; ADMINISTRATION, CUTANEOUS; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CESAREAN SECTION; CHLORHEXIDINE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; POVIDONE-IODINE; PREGNANCY; PREOPERATIVE CARE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84948076245     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001118     Document Type: Article

References (21)

1. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Multistate point-prevalence survey of health care associated infections. N Engl J Med 2014;370:1198-208.
2. Olsen MA, Butler AM, Willers DM, Gross GA, Hamilton BH, Fraser VJ. Attributable costs of surgical site infection and endo-metritis after low transverse cesarean delivery. Infect Control Hosp Epidemiol 2010;31:276-82.
3. Hadiati DR, Hakimi M, Nurdiati DS. Skin preparation for preventing infection following caesarean section. The Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD007462. DOI: 10.1002/14651858.CD007462.pub2.
4. Noy D, Creedy D. Postdischarge surveillance of surgical site infections: a multi-method approach to data collection. Am J Infect Control 2002;30:417-24.
5. Darouiche RO, Wall MJ Jr, Itani KM, Otterson MF, Webb AL, Carrick MM, et al. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med 2010;362: 18-26.
6. Dahlke JD, Mendez-Figueroa H, Rouse DJ, Berghella V, Baxter JK, Chauhan SP. Evidence-based surgery for cesarean delivery: an updated systematic review. Am J Obstet Gynecol 2013;209:294-306.
7. Stinner DJ, Krueger CA, Masini BD, Wenke JC. Time-dependent effect of chlorhexidine surgical prep. J Hosp Infect 2011;79:313-6.
8. Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982;15:635-9.
9. Anderson MJ, Horn ME, Lin YC, Parks PJ, Peterson ML. Efficacy of concurrent application of chlorhexidine gluconate and povidone iodine against six nosocomial pathogens. Am J Infect Control 2010;38:826-31.
10. Horan T, Gaynes R, Martone W, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-8.
11. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:247-78.
12. Tran TS, Jamulitrat S, Chongsuvivatwong V, Geater A. Risk factors for postcesarean surgical site infection. Obstet Gynecol 2000;95:367-71.
13. Mackeen AD, Schuster M, Berghella V. Suture versus staples for skin closure after cesarean: a metaanalysis. Am J Obstet Gynecol 2015;212:621.e1-10.
14. Young H, Knepper B, Vigil C, Miller A, Carey JC, Price CS. Sustained reduction in surgical site infection after abdominal surgery. Surg Infect 2013;14:460-3.
15. Dumville JC, McFarlane E, Edwards P, Lipp A, Holmes A. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. The Cochrane Database of Systematic Reviews 2013, Issue 3. Art. No.: CD003949. DOI: 10. 1002/14651858.CD003949.pub4.
16. Wloch C, Wilson J, Lamagni T, Harrington P, Charlett A, Sheridan E. Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study. BJOG 2012;119:1324-33.
17. Ghuman M, Rohlandt D, Joshy G, Lawrenson R. Post-caesar-ean section surgical site infection: rate and risk factors. N Z Med J 2011;124:32-6.
18. Shaffer VO, Baptiste CD, Liu Y, Srinivasan JK, Galloway JR, Sullivan PS, et al. Improving quality of surgical care and outcomes: factors impacting surgical site infection after colorectal resection. Am Surg 2014;80:759-63.
19. Lim S, Edelstein AI, Patel AA, Kim BD, Kim JY. Risk factors for postoperative infections following single level lumbar fusion surgery. Spine (Phila Pa 1976) 2014 [Epub ahead of print].
20. Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet 2005;90:10-5.
21. Tita AT, Andrews WW. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 2010;37:339-54.